Venus Medtech and Healium form joint venture for RDN products

Venus Medtech (Qiming Medical) announced a joint venture with Israeli company Healium to form Renaly, which will develop, manufacture and commercialize Healium's next-generation renal denervation (RDN) devices globally. Venus Medtech will be the controlling shareholder.

“启明医疗-B(02500)发布公告，已与以色列高科技公司Healium成立合资公司Renaly，以引进Healium的新一代去肾交感神经术(RDN)创新器械。”beta.zhitongcaijing.com

• 1 source
• beta.zhitongcaijing.com启明医疗-B(02500)与Healium成立合资公司拟将RDN产品在全球范围内进行研发，生产及商业化Jun 30, 2021

Summarized from public sources; check the original articles before acting on it.